1. Home
  2. RLMD vs AMOD Comparison

RLMD vs AMOD Comparison

Compare RLMD & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • AMOD
  • Stock Information
  • Founded
  • RLMD 2004
  • AMOD 2014
  • Country
  • RLMD United States
  • AMOD United States
  • Employees
  • RLMD N/A
  • AMOD N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • AMOD
  • Sector
  • RLMD Health Care
  • AMOD
  • Exchange
  • RLMD Nasdaq
  • AMOD NYSE
  • Market Cap
  • RLMD 22.0M
  • AMOD 18.7M
  • IPO Year
  • RLMD N/A
  • AMOD N/A
  • Fundamental
  • Price
  • RLMD $0.61
  • AMOD $1.18
  • Analyst Decision
  • RLMD Buy
  • AMOD
  • Analyst Count
  • RLMD 3
  • AMOD 0
  • Target Price
  • RLMD $5.00
  • AMOD N/A
  • AVG Volume (30 Days)
  • RLMD 338.9K
  • AMOD 194.0K
  • Earning Date
  • RLMD 08-06-2025
  • AMOD 08-15-2025
  • Dividend Yield
  • RLMD N/A
  • AMOD N/A
  • EPS Growth
  • RLMD N/A
  • AMOD N/A
  • EPS
  • RLMD N/A
  • AMOD 0.12
  • Revenue
  • RLMD N/A
  • AMOD N/A
  • Revenue This Year
  • RLMD N/A
  • AMOD N/A
  • Revenue Next Year
  • RLMD N/A
  • AMOD N/A
  • P/E Ratio
  • RLMD N/A
  • AMOD $10.35
  • Revenue Growth
  • RLMD N/A
  • AMOD N/A
  • 52 Week Low
  • RLMD $0.24
  • AMOD $1.01
  • 52 Week High
  • RLMD $4.47
  • AMOD $13.49
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 47.74
  • AMOD N/A
  • Support Level
  • RLMD $0.60
  • AMOD N/A
  • Resistance Level
  • RLMD $0.69
  • AMOD N/A
  • Average True Range (ATR)
  • RLMD 0.07
  • AMOD 0.00
  • MACD
  • RLMD -0.01
  • AMOD 0.00
  • Stochastic Oscillator
  • RLMD 41.86
  • AMOD 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About AMOD ALPHA MODUS HOLDINGS INC

Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing, and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.

Share on Social Networks: